glp-1 agonist dpp 4 inhibitor dpp-4_inhibitors [TUSOM Were DPP-4 inhibitors the original
Description
1) CT 388 has shown a placebo-adjusted WL of 8.5% after 4 weeks in a phase 1 trial [50]
[DOI] [PMC free article] [PubMed] [Google Scholar] 116.Fulton S, Horn CC, Zhang C
M., Lehto, S., Ronnemaa, T., Pyorala, K
GLP-1 and Nausea: How to Combat This Side Effect GLP-1 receptor agonists are widely used for weight management and diabetes treatment, offering significant benefits such as improved blood sugar control and appetite regulation
10.1097/FJC.0b013e31826be204 19
Deane AM, et al
